Percutaneous cement augmentation for osteoporotic vertebral fractures

[摘要] Vertebral fractures in general, and thoracolumbar (TL) fractures in particular, are the second most frequent fractures after hip fractures.1,2 TL fractures at the TL junction (T11- L2) account for three-quarters of total spinal injuries.3 There are two peak incidences for vertebral fractures: at a young age with motor vehicle accidents as the most common cause and in the older population as one of the markers of osteoporosis.4 Osteoporotic vertebral fractures (OVF) affect 117 in 100000 people1 and are often related to a minor trauma, such as a fall, or may even happen spontaneously, without relating to any minor trauma.5 OVF are generally type A1 or A3.1 fractures in the Arbeitsgemeinschaft für Osteosynthesefragen (AO) classification.6 OVF are associated with a greater impact on health-related quality of life than other fragility fractures.4 Standard therapy of these fractures consists of rest, analgesia and mobilisation, and is often poorly tolerated in elderly people, with the adverse effects of analgesia and immobilisation leading to associated health problems (poor cognition, increased risk of falls, constipation and nausea).7 MRI is of primary importance to show an area of hyperintensity signal on T2 scans, a marker of oedema that is correlated with pain levels and to non-surgical management success (Fig. 1).8 Percutaneous treatment of these types of fractures consists of bone cement augmentation with or without the use of posterior instrumentation.

[学科分类] 神经科学

[关键词] osteoporotic vertebral fracture;kyphoplasty;vertebroplasty;bone cement